Unraveling the chemistry of chemokine receptor ligands

被引：45

作者：

Gao, ZL ^{[1
]}

Metz, WA ^{[1
]}

机构：

[1] Aventis Pharmaceut, Med Chem, Bridgewater, NJ 08807 USA

来源：

CHEMICAL REVIEWS | 2003年 / 103卷 / 09期

关键词：

D O I：

10.1021/cr020474b

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

The study of chemokine receptors and their ligands is a rapidly growing and intense area of research in drug discovery. There is now extensive evidence for the involvement of chemokines in many disease pathways, and thus continued research to discover small-molecule chemokine receptor antagonists for these targets is warranted. To date, there has been significant progress in the identification of small-molecule nanomolar chemokine antagonists that are bioavailable. It is extremely encouraging that this class of GPCRs can be antagonized with low-molecular-weight small organic compounds.

引用

页码：3733 / 3752

页数：20

共 147 条

[1] The CC chemokines MDC and TARC induce platelet activation via CCR4 [J].

Abi-Younes, S ;

Si-Tahar, M ;

Luster, AD .

THROMBOSIS RESEARCH, 2001, 101 (04) :279-289

[2] CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B - Determinants of high affinity binding and receptor activitation are distinct [J].

Ahuja, SK ;

Lee, JC ;

Murphy, PM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :225-232

[3]

AQUARO S, 2002, ANTIVIR RES, V53, P3

[4]

Auten RL, 2001, J PHARMACOL EXP THER, V299, P90

[5] Chemokines and leukocyte traffic [J].

Baggiolini, M .

NATURE, 1998, 392 (6676) :565-568

[6] Chemokines and their receptors in the central nervous system [J].

Bajetto, A ;

Bonavia, R ;

Barbero, S ;

Florio, T ;

Schettini, G .

FRONTIERS IN NEUROENDOCRINOLOGY, 2001, 22 (03) :147-184

[7] CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].

Balashov, KE ;

Rottman, JB ;

Weiner, HL ;

Hancock, WW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878

[8] Cutting edge: Eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils [J].

Bandeira-Melo, C ;

Sugiyama, K ;

Woods, LJ ;

Weller, PF .

JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :4813-4817

[9] CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis [J].

Barcellos, LF ;

Schito, AM ;

Rimmler, JB ;

Vittinghoff, E ;

Shih, A ;

Lincoln, R ;

Callier, S ;

Elkins, MK ;

Goodkin, DE ;

Haines, JL ;

Pericak-Vance, MA ;

Hauser, SL ;

Oksenberg, JR .

IMMUNOGENETICS, 2000, 51 (4-5) :281-288

[10]

BAUMAN JG, 1999, Patent No. 09856771

← 1 2 3 4 5 6 7 8 9 10 →